The University of Utah Health is partnering with the state to launch the Center for Medical Cannabis Research (CMCR) which aims to “advance scientific understanding of medical cannabis and help patients and providers make informed health decisions about this increasingly common medication.” Valerie Ahanonu, B.S., senior manager of the CMCR, said in a statement that the center’s overall aim is to “look at the methodology behind how people are using cannabis, and to create a translational approach to understanding its benefits… Read more.
Your daily dose of news & information.
An Arizona Psilocybin Research Advisory Council will meet for the first time on Tuesday to start the process of providing millions of dollars in grant funding to support research into the therapeutic potential of psychedelic mushrooms. The council—which was established under the Arizona Department of Health Services (ADHS) as part of large-scale budget legislation that the governor signed in May—is meeting about a month before officials plan to open an application period for potential grant recipients. The legislature has appropriated $5… Read more.
Another federally funded study is suggesting that marijuana legalization may be linked to a “substitution effect,” with young adults in California “significantly” reducing their use of alcohol and cigarettes after the cannabis reform was enacted. What’s more, the research appeared to contradict prohibitionist arguments about the potential impact of legalization, as the data also revealed no significant increase in marijuana use among young adults who were still not of age to access retail dispensaries—though there were interesting changes in certain… Read more.
Researchers at a university in Sweden are using acid and ketamine to better understand the workings of the brain, which would then lead to the development of artificial intelligence. The researchers, based at Lund University in Lund, Sweden, “have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats,” the school said in a press release earlier this year. The study has drawn recent media coverage from both Reuters and the British tabloid Metro. The university said that… Read more.
The cannabis component CBD can alleviate acute dental pain and may provide an equally effective, far safer alternative to opioids, researchers at Rutgers University and the University of Texas say in newly published research. “Our results indicate that a single dose of CBD is as potent as current analgesic regimens and can manage emergency dental pain effectively,” the authors wrote in the study, published this month in the Journal of Dental Research. They said their work appears to be “the… Read more.
According to a survey conducted by EO Care, Inc., 88% of medical cannabis users reported that it reduced their reliance on prescription drugs, alcohol, or both. Additionally, 51% of respondents expressed a likelihood or strong inclination to utilize cannabis if it were offered through their health plan. This survey encompassed 1,027 participants from states where cannabis was legally accessible for either medical or recreational use. It also revealed that 65% of those surveyed would feel more at ease using cannabis for medical purposes if… Read more.
Massachusetts Governor Maura T. Healey last week filed legislation to increase benefits and modernize services for the state’s military veterans that includes a proposal to study the medical benefits of psychedelic drugs. The bill, known as an Act Honoring, Empowering and Recognizing Our Servicemembers and Veterans (HERO Act), was unveiled on November 9 by Healey and Lieutenant Governor Kim Driscoll at the Massachusetts Executive Office of Veterans Services. The Healey administration said in a statement that the legislation would positively impact the… Read more.
The odds that a patient visiting the emergency department is diagnosed with cannabis use disorder (CUD) is nearly 50 percent lower in states that have legalized marijuana compared to non-legal states, according to a new study. And researchers say the “counterintuitive” finding could be related to the destigmatization of cannabis use within the medical community as prohibition ends. The study, published in the journal Preventative Medicine Reports last week, looked at emergency department data from 2017 to 2020 in two… Read more.
The National Institutes of Health (NIH) is soliciting proposals to develop psychedelics into treatments for substance use disorder (SUD), with plans to issue $2 million in grant money toward the research projects during fiscal year 2025. The funding opportunity will support research into a range of substances that might be used treat addiction, including “classic psychedelics” such as psilocybin and LSD, empathogens such as MDMA, dissociatives such as ketamine and other hallucinogens, including ibogaine and its analogues. The NIH listing… Read more.
A new study has determined that customized cannabis treatments can improve the quality of life for patients with autism spectrum disorder. The study of 20 patients with autism found that participants who took a customized daily regimen of full-spectrum cannabis extracts showed a significant improvement in their symptoms resulting in an improvement in the quality of life for both the patients and their families. The small study, which was conducted by Brazilian researchers monitored by a University of Brasília ethics… Read more.
A study published in September in the journal Psychedelic Medicine found a majority of respondents – randomly selected American Psychiatric Association (APA) members – moderately or strongly believed that hallucinogens show promise in treating psychiatric conditions (80.9%) and substance use disorders (60.8%). A majority of those surveyed also moderately or strongly supported research into hallucinogens‘ therapeutic potential for psychiatric conditions (93.9%) and substance use disorders (88.6%), as well as federal funding of associated clinical trials – 84.7% and 80.9%, respectively. The survey was… Read more.
The Washington State Department of Commerce released a document this week recommending how $200 million should be spent to address racial, economic and social disparities created by the war on drugs. The 92-page Community Reinvestment Plan was developed by the department, the state Office of Equity and the Harriet Tubman Foundation for Safe Passage, which together worked with community members to advise how the reinvestment money should be spent. The plan, paid for out of the state’s general fund, next… Read more.
The Drug Enforcement Administration (DEA) is proposing a dramatic increase in its 2023 production quotas for marijuana compounds and psychedelics like psilocybin and ibogaine to “support research and clinical trials” into the substances. DEA wants to nearly double the amount of psilocybin, psilocyn and delta-9 THC that’s manufactured compared to initial levels set for this year, while quintupling how much ibogaine is produced. It also wants 23 times as much of “other tetrahydrocannabinol,” raising the quota from 15,000 grams to… Read more.
The National Institutes of Health (NIH) is calling for the creation of a centralized marijuana research center that’s designed to help scientists overcome barriers to studying cannabis under federal prohibition. In a notice of funding opportunity posted on Thursday, NIH said it’s looking for an eligible entity to operate a new Resource Center for Cannabis and Cannabinoid Research through a cooperative agreement in order to “address challenges and barriers to conducting research on cannabis and its constituents.” The center should… Read more.
The federal health agency is awarding researchers $3.2 million to study the effects of using cannabis while receiving immunotherapy for cancer treatment, as well as whether access to marijuana helps reduce health disparities. The University of Buffalo (UB) announced that one of its psychiatrists has received the research grant funding from the National Institutes of Health’s (NIH) National Cancer Institute, which will go toward a year-long study to assess how the common cancer treatment is affected by patients’ cannabis use.… Read more.
While many marijuana enthusiasts believe that components called terpenes are responsible for strains’ distinctive smells, a new study published by the American Chemical Society has identified “previously undiscovered cannabis compounds” that challenge that conventional wisdom of what really gives each variety its unique olfactory profile. The research, conducted by a team of scientists from marijuana extraction and testing companies and published this month in the journal ACS Omega, says that “while aroma is a key property in differentiating cannabis varieties… Read more.
Agricultural scientists at Texas’ Prairie View A&M University (PVAMU) have received a $299,162 grant from the United States Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to study the use of hemp as animal feed. The three-year study will be conducted by research scientists from the university’s Department of Agriculture, Nutrition and Human Ecology and will focus on the nutritional profile of industrial hemp plant biomass byproducts, and their impact on goats, to determine if hemp biomass can… Read more.
A study published last month in the journal Scientific Reports suggests that individuals who use psychedelics tended to have better mental health outcomes during the coronavirus pandemic than non-users. The researchers concluded that “users of hallucinogenic drugs scored better on various dimensions that were clearly affected by the recent COVID-19 pandemic, like psychopathology, wellbeing, and post-traumatic growth. This was even clearer in the case of regular users of these drugs.” For the study, researchers recruited a sample of 2,971 participants for… Read more.
A recent study found that when states adopt recreational cannabis laws, admissions for mental health treatment drop. The study, published in the journal Health Economics, is notable given growing questions about cannabis’ impact on mental health. Over the past two decades, numerous states have legalized cannabis use for adults. Unfortunately, research on how cannabis impacts mental health is mixed. Some studies have found cannabis helpful for some mental health conditions, while others suggest cannabis’ potential to worsen certain conditions. Because of this complex picture, some have worried that cannabis… Read more.
The Harvard Gazette announced that the venerable Ivy League University will create a Study of Psychedelics in Society and Culture with a multi-million dollar gift from the Gracias Family Foundation. According to the announcement, the study will be interdisciplinary across the Faculty of Arts and Sciences, Harvard Law School, and Harvard Divinity School. “We are thrilled to have the opportunity to bring students, faculty, and researchers together around the important issue of how psychedelics impact our society,” said Robin Kelsey, Shirley Carter… Read more.
Cannabis consumers who contracted COVID-19 had reduced mortality and better outcomes compared to non-consumers, according to a study published this month in the CHEST Journal. The study, using the National Inpatient Sample Database, suggests “the beneficial effect of marijuana use may be attributed to its potential to inhibit viral entry into cells and prevent the release of proinflammatory cytokines, thus mitigating cytokine release syndrome.” According to the study, titled “Exploring the Relationship Between Marijuana Smoking and Covid-19 Outcomes,” cannabis consumers that had… Read more.
Planting hemp as a cover crop in wine vineyards could be beneficial, according to a study conducted by New Zealand researchers outlined by New Zealand Wine Grower. The research, conducted over three years in Marlborough Sauvignon Blanc vineyards by grape grower Kirsty Harkness and viticulture researcher Dr. Mark Krasnow, found the hemp did not compete with the vines and beneficially affected the soils and wines. Additionally, the hemp became established without supplemental irrigation during an exceptionally dry season when other cover crops failed… Read more.
A recent paper published in the European Journal for Chemistry explores the historical use of cannabis and its versatility. Entitled “From ancient Asian relics to contemporaneity: A review of historical and chemical aspects of Cannabis,” researchers Gabriel Vitor de Lima Marques and Renata Barbosa de Oliveira from the Brazil-based Federal University of Minas Gerais’ Department of Pharmaceutical Products, submitted the paper earlier this year in April, and it was printed in the journal in late September. “From the Himalayan mountains to the… Read more.
Signature gathering has officially kicked off to qualify an initiative for California’s 2024 ballot that would spend $5 billion to create a state agency focused on advancing research and development of psychedelic therapies. Known as the TREAT California Act, the measure would not itself change the legal status of any substances. Rather, it would establish a state agency called the Treatment, Research, Education, Access and Therapies (TREAT) Institute, which would identify opportunities for advancing scientific research and development into the therapeutic… Read more.
A new study shows that the effects of whole-plant cannabis products produce stronger psychoactive effects that last longer than products that are nearly pure THC. The research gives additional evidence for the so-called entourage effect, a hypothesis that cannabis compounds other than THC work synergistically to modulate the overall effects of the plant. Long an element of cannabis lore, the entourage effect holds that cannabis provides the most benefits when used as a whole-plant extract, incorporating all its cannabinoids, terpenes… Read more.
Due to the growing acceptance of cannabis, particularly for medical purposes, scientists are increasingly eager to delve into its impact on health. A particular area of interest lies in exploring how marijuana might affect fertility. Researchers are actively investigating the potential consequences of smoking marijuana on male fertility. Recent studies have revealed concerning trends, indicating that men in Western nations grapple with a fertility crisis. Specifically, the sperm count among males of reproductive age decreased by more than half between 1973 and 2011.… Read more.
What The Israelis Are Currently Studying In The Psychedelic Field For several decades now, Israel has been a global leader when it comes to scientific marijuana research. It was also Dr. Raphael Mechoulam, an Israeli chemist, who was responsible for first isolating THC and labeling it as the primary psychoactive compound in the plant back in 1965. Israel is far more advanced compared to any country in the world when it comes to cannabis research, even the US. That’s because the federal government still… Read more.
At a U.S. Department of Health and Human Services (HHS) workshop about psychedelic medicine earlier this month, the director of mental health for the Department of Veterans Affairs (VA) said she thinks research into psychedelic-assisted therapy needs to more closely resemble real world scenarios. Requiring subjects to have specific diagnoses and pass strict screening protocols, she said, makes it impossible to accurately generalize the effects of such treatment on patients. “There has been great interest in this,” said Rachel Yehuda,… Read more.
One of the most prominent effects of marijuana use is the undeniable craving for food that often ensues, commonly referred to as "the munchies." When this sensation takes hold, no bag of chips, pack of Oreos, or any other sugary, salty, or fatty indulgence is spared. Interestingly, one might assume that all this snacking would lead to users piling on extra pounds. However, a recent study suggests that the opposite might be true. In this study, researchers scrutinized Body Mass Index… Read more.
As the legalization of recreational marijuana spreads across the United States, there is growing curiosity about its impact on the brain, including concerns about potential harm to brain cells. Just as the prolonged use of alcohol, methamphetamine, and heroin can lead to irreversible brain damage, excessive and extended marijuana use can disrupt the normal functioning of brain cells. This ultimately affects their ability to transmit messages (a process called brain activity). Using marijuana can damage brain cells, which in turn can manifest… Read more.
New Study Shows That Cannabis Extracts Are Useful For Autism - Promising Benefits Of CBD For Autism According to the World Health Organization, 1 in every 100 children have autism. While the symptoms of autism vary greatly, kids who grow up with autism can struggle with many aspects of life. These include challenges in communication, learning, socialization, and behavior. As a result, this can affect their families, personal relationships, and work. Medical professionals now have a wide range of treatments available for autism, ranging… Read more.
According to a study conducted by scholars from Columbia University Mailman School of Public Health and Oregon State University, utilizing national data, it was discovered that in states where recreational marijuana had been legalized, non-college-bound young adults exhibited a higher propensity to become frequent marijuana users compared to their counterparts in states where it remained illegal. These research findings have been documented in the American Journal of Preventive Medicine. Following the legalization of marijuana at the state level, it was observed that… Read more.
It’s Friday afternoon and you’re leaving work early. You’re ready to ease into the weekend slowly and steadily, opting for mindful relaxation over nihilistic raging. Instead of heading over to a happy hour, you decide to unwind with some cannabis. You want enough for the whole weekend. Knowing from experience, at least one other person (who never seems to have any of their own) will ask you to share. So, while your housemate or partner heads into the shop for… Read more.
A study published last month in the Journal of Cannabis Research suggests that the majority of hemp-derived delta-9 THC products do not state the product’s correct dosage of the cannabinoid on the package and that most of the companies that provided laboratory reports did not actually check for impurities. The study included 53 hemp-derived delta-9 THC products. The products were sent to InfiniteCAL laboratory which tested potency, the presence of impurities, and whether the delta-9 THC present was natural or converted from CBD. The presence… Read more.
States that legalized medical marijuana saw a nearly 20 percent drop in the number of children entering foster care due to parental drug misuse after three years of the reform, a new study found. Legalizing for adult use, meanwhile, was not associated with any statistically significant change in foster care entries. Researchers at Georgia College and State University set out to learn whether legalization would “lessen stigma, permit proper use, and reduce the chance that a child will be removed”… Read more.
A new study suggests that some lesser-known cannabinoids produced by hemp and marijuana—with names like THCV, CBDV, CBC, CBM and CBN—may help treat dermatological diseases such as psoriasis, eczema and acne. “The findings of this review suggest that minor cannabinoids hold therapeutic promise in the management of dermatological diseases,” says the study, published this week in the peer-reviewed journal Molecules. “Incorporating minor cannabinoids into dermatological therapies could potentially offer novel treatment options of patients and improve their overall well-being.” To… Read more.
Middle-aged adults with a history of cannabis use over the previous year did not have a higher risk of suffering a heart attack, according to the results of a recent study by researchers at the University of California in San Diego. The new study, “Associations Between Monthly Cannabis Use and Myocardial Infarction in Middle-Aged Adults: NHANES 2009 to 2018,” was published on August 7 in the peer-reviewed American Journal of Cardiology, found that a history of cannabis use over the previous… Read more.
NIH Survey Finds Cannabis Use Among Adults Highest Ever Recorded by Agency In 2021, the Monitoring the Future (MTF) panel study revealed noteworthy shifts in substance use patterns among young adults aged 19 to 30. Notably, the utilization of marijuana and hallucinogens within the past year experienced a significant surge compared to data from five and ten years prior. This surge marked a historic pinnacle for this age group since 1988. Simultaneously, the prevalence of nicotine vaping in the past month… Read more.
Psilocybin therapy's role in addiction treatment is not a recent exploration. Recent studies have notably illuminated the burgeoning potential of this emerging psychedelic therapy. It exhibits promise in aiding individuals contending with substance use disorders, spanning the realms of alcohol and nicotine addiction. These studies underscore the growing interest in harnessing psilocybin's therapeutic effects to address the complex challenges of addiction, potentially opening doors to innovative and effective approaches for those in need. Originating from the appropriately labeled "magic" mushrooms, this compound's extensive… Read more.
A new study in the International Journal of Drug Policy found that states with legal medical marijuana enjoyed significant reductions in health insurance premiums compared to states where cannabis remained completely illegal. Analyzing a decade’s worth of private health insurance data from the National Association of Insurance Commissioners, researchers determined that in the years following a state’s implementation of a medical cannabis law, premiums dropped dramatically. While the reductions were modest immediately following implementation, the study found that by seven… Read more.
People increasingly view smoking marijuana or being exposed to secondhand cannabis smoke as safer than smoking or being near tobacco smoke, according to a new study published by the American Medical Association (AMA). Researchers surveyed 5,035 U.S. adults three times—in 2017, 2020 and 2021—about how they perceive the risks of both substances, and they found a “significant shift” over time as more people expressed that they felt cannabis smoke was generally safer than tobacco smoke. The survey—results of which were… Read more.
New Hampshire Gov. Chris Sununu (R) on Tuesday signed the bill to create a cannabis legalization study commission, the New Hampshire Bulletin reports. The commission will evaluate how, and whether, cannabis could be sold through state-owned shops rather than private retailers. Cannabis use and possession is currently not legal in New Hampshire. In 2017, the state decriminalized possession of up to three-quarters of an ounce and anyone caught with less than that may be fined but not arrested. Sununu, who is not running for… Read more.
States With Legal Recreational Weed See A Reduction In Mental Health Treatment New Study Shows Other Positive Benefits Of Adult Use Laws Marijuana is not only a safe drug, it benefits society as a whole. There have been several studies pointing to the societal benefits of cannabis because the truth is that – it is simply not harmful to families and society, the way prohibitionists say it is. In fact, the opposite is true: studies have been showing that legalizing cannabis makes cities… Read more.
Atai Life Sciences (NASDAQ: ATAI) announced results from Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of PCN-101 (R-ketamine). The small study seemed to deliver positive results, but it also looks as if Atai needs a partner before moving forward with the drug. The study enrolled 16 healthy volunteers, each into one of four sequences of administration. The Phase 1 open-label, 4-period crossover study assessed the safety, tolerability, and pharmacokinetic profile of 60mg, 90mg and 120mg of PCN-101 delivered subcutaneously as compared to 60mg of… Read more.
Michigan’s Wayne State University this fall semester will begin offering a cannabis chemistry undergraduate certificate. The 15-credit hour program will focus on instrumentation, standard operating procedures, business and law practices, and science behind the testing and regulation of cannabis. The certificate program will be housed in the College of Liberal Arts and Sciences and administered by the Department of Chemistry. It will require five classes and a research course. In a statement, Andrea Matti, assistant professor of teaching in the… Read more.
The cannabis business background of Massachusetts’ director of marijuana testing is raising eyebrows among industry watchers already concerned about the way state regulators are treating MJ companies. James Kocis became the director of testing for the Massachusetts Cannabis Control Commission (CCC) last October after years of working in the marijuana testing industry. At a legislative hearing last week, a lobbyist representing local testing labs called the CCC “unpredictable” and “unaccountable.” A testing industry executive, meanwhile, alleged that Massachusetts faces “a… Read more.
The U.S. House of Representatives has approved amendments to a large-scale spending bill that would allow U.S. Department of Veterans Affairs (VA) doctors to recommend medical cannabis to military veterans and promote research into substances like psilocybin and MDMA. Just one day after the House Rules Committee made the measures in order for floor consideration, they passed on the floor on Wednesday and are advancing as part of appropriations legislation covering Military Construction, Veterans Affairs and Related Agencies (MilCon/VA). The medical… Read more.
A recent study revealed that more than 90% of U.S. military veterans using medical marijuana reported significantly improving their quality of life. These veterans have turned to cannabis as a substitute for over-the-counter and prescription medications. Details Of The Study In a comprehensive study conducted by researchers from the University of Utah, the University of Massachusetts, and various cannabis research institutes, a group of 510 veterans who use marijuana participated in a self-reported survey to gain deeper insights into their usage patterns… Read more.
Over 90 percent of U.S. military veterans who use medical marijuana say that it improves their quality of life, with many using cannabis as an alternative to over-the-counter and prescription medications, according to a new study. Researchers at the University of Massachusetts, University of Utah and cannabis research institutes looked at self-reported survey data from 510 veterans who said that they consume marijuana, seeking to better understand the purpose and experiences of their usage. A majority of the respondents (67… Read more.
Cannabis continues to emerge as a substitute for alcohol among consumers, particularly for the Gen Z demographic, according to a report by data firm Brightfield Group. The findings show that an evolving social landscape and heightened health consciousness are influencing consumers to adjust their drinking habits. Since 2021, there has been a notable shift in alcohol consumption trends, with Brightfield Group’s research indicating that 60% of alcohol consumers are drinking less as of the first quarter of 2023, a 3% rise from when… Read more.
A new study has shown that cannabis use during pregnancy is not associated with differences in the neurodevelopment of children exposed to cannabis in the womb. The study, which was published last month in the peer-reviewed journal Paediatric and Perinatal Epidemiology last month, found that prenatal cannabis exposure was not associated with lower scores on neuropsychological tests in children or with autism among young adults. “Prenatal marijuana exposure was not associated with secondary outcomes or risks of clinical deficit in any neuropsychological… Read more.
At least five states with medical marijuana programs have shared key data – including the products patients are using and how they are affected – with U.S. health regulators as part of the Biden administration’s review of whether to remove marijuana from the federal government’s list of the most dangerous drugs, MJBizDaily has learned. The state data sent to the U.S. Food and Drug Administration and the Department of Health and Human Services (HHS) offers federal researchers a wider and deeper look… Read more.
The University of California, San Diego Psychedelics and Health Research Initiative has received a $1.5 million gift to study the effects of DMT on the brain. Philanthropist Eugene Jhong gifted the funds to the university for the research. Jon Dean, PhD, a postdoctoral scholar in the UC San Diego Department of Anesthesiology and director of the Division of DMT Research at the UC San Diego Psychedelic Health and Research Initiative, is one of the principal investigators of the study. In… Read more.
The US Food and Drug Administration (FDA) has issued new draft guidance that highlights key considerations for researchers conducting clinical trials of psychedelic drugs for the treatment of medical conditions. The move, which was announced by the agency on June 23, marks the first time the FDA has issued guidance for investigating psychedelics, including psilocybin, LSD and MDMA, which have shown potential as possible treatments for serious mental health conditions. The guidance “describes basic considerations throughout the drug development process including… Read more.
Savvy consumers have become less common across cannabis users. Cannabis consumer behavior is shifting – and with it the future of the cannabis industry, according to a new report from cannabis firm New Frontier Data The report, “Cannabis Consumers in America 2023 Part 2: Exploring the Archetypes,” scrutinizes the shifts by examining nine cannabis consumer archetypes, updated with the firm’s latest 2023 consumer survey data. Frequent Users Savvy Connoisseurs, which account for 13% of consumers, use cannabis multiple times per… Read more.
A recent study suggests a decline in teen binge drinking follows the passage of adult-use cannabis laws, but researchers also noted an increase in binge drinking among adults 31 and older. The study, “Recreational cannabis legislation and binge drinking in U.S. adolescents and adults,” used data from the National Survey on Drug Use and Health from 2008-2019. The researchers found that, during that period, binge drinking declined overall among people aged 12-20 (17.54% to 11.08%), and those aged 21-30 (43.66% to 40.22%), but binge… Read more.
The U.S. Food and Drug Administration (FDA) on Monday released its Draft Guidance for research of psychedelic drugs. The guidance covers psilocybin, LSD, and substances such as MDMA. The guidance mirrors the good practices required by other drug and therapeutic companies, including compliance with the federal Food, Drug, and Cosmetics Act and that non-clinical investigations should follow 2010’s Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. The guidance also details which psychedelic drugs would be considered botanical… Read more.
Upset with the predicament he's in, The Dude in The Big Lebowksi, played by Jeff Bridges, accuses the man who shares his namesake, played by Davis Huddleston: "You human paraquat!" In 1998, that was quite the nonsequitor. But fans of the movie know Jeff Lebowski (a.k.a. The Dude) was a '60s student radical who would've been awae of the paraquat controversy in the '70s. These days, paraquat – a chemical pesticide – is best known as a cause of Parkinson's disease. Ads run regularly on… Read more.
Federally legalizing marijuana is both doable for the Biden administration and relatively easy, according to a new white paper that makes the case for reform. The paper, released Monday by the Coalition for Cannabis Scheduling Reform, prioritizes “de-scheduling” – or removing marijuana from the list of federally controlled substances altogether – but also acknowledges that “rescheduling” marijuana to Schedule 3 or lower would be “a historic step along the path to necessary reform.” The white paper was issued in the midst… Read more.
A Democratic congressman says that it’s time for Congress to give the U.S. Department of Veterans Affairs (VA) a mandate to study the benefits and risks of marijuana for military veterans. At a Member Day hearing before the House Veterans’ Affairs Committee on Thursday, Rep. Lou Correa (D-CA) urged the panel to advance his bipartisan bill, the VA Medicinal Cannabis Research Act. Back when he was serving in the California legislature, Correa said veterans started approaching him—”slowly, gradually but firmly”—and describing… Read more.
A significant player in the psychedelics industry has received a $5 million infusion from hedge-fund billionaire and New York Mets owner Steve Cohen and his wife, deepening the couple’s efforts to bring mind-altering therapies into the mainstream. The Steven & Alexandra Cohen Foundation is donating the funds to MAPS, or the Multidisciplinary Association for Psychedelics Studies, a nonprofit that has pushed for more research on psychedelic drugs since 1986. The organization is engaged in a financially-intensive push to get the… Read more.
Congressional Committee Approves GOP-Led Marijuana ‘Pilot Program’ And Psychedelics Study Amendments To Military Bill
A congressional committee has approved a large-scale defense bill that includes GOP-led provisions to create a medical marijuana “pilot program” and require a study into the therapeutic potential of psychedelics for active duty military members under the U.S. Department of Defense (DOD). The House Armed Services Committee held a markup of the National Defense Authorization Act (NDAA) on Wednesday, approving the legislation with drug policy reform amendments from Reps. Nancy Mace (R-SC) and Morgan Luttrell (R-TX), which were both adopted… Read more.
The National Football League (NFL) and its players union announced on Thursday that they are jointly awarding another round of funding to support independent research on the therapeutic benefits of CBD as a pain treatment alternative to opioids for players with concussions. A total of $526,525 is being granted for two studies, including one that will be led by the American Society of Pain and Neuroscience (ASPN) to explore cannabidiol and non-invasive vagal nerve stimulation (nVNS) as alternative treatments for… Read more.
A survey by the American Psychiatric Association (APA) and Morning Consult found Americans believe cannabis is less harmful than cigarettes, vapes, alcohol, and prescribed and non-prescribed opioids but more harmful than technology. The survey also found that respondents believed that cannabis was less addictive than cigarettes, vapes, alcohol, prescribed and non-prescription opioids, and technology. In a statement, APA President Dr. Petros Levounis said the survey showed “It is clear that we have gotten the message through that cigarettes are dangerous and addictive.”… Read more.
Both companies plan to use some of the proceeds to further their research. While funding for psychedelics companies may be becoming more scarce, at least two firms have managed to successfully initiate rounds recently. PharmAla Psychedelic drug company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF) announced a non-brokered private placement of a minimum 3,333,333 units and a maximum 16,666,666 units of the company at a price of $0.30 per unit for gross proceeds of a minimum of $1 million and a maximum of… Read more.
According to the Colorado Marijuana Enforcement Division (MED), state investigators have uncovered numerous instances of marijuana product adulteration by businesses attempting to manipulate contaminant testing. Since the commencement of recreational marijuana sales in Colorado, contamination from mold or illegal pesticides has persisted as a significant issue. As reported by MJ BIZ, in 2021, the MED approved decontamination and remediation methods for failed marijuana batches; however, these approaches can be expensive and do not guarantee the successful salvage of the harvests. In a memo dated… Read more.
Researchers Aim To Combine Psilocybin and Cannabis Into Single Medical Treatment According to a product patent from the renowned marijuana laboratory, CaaMTech, substantial strides have been made in developing a comprehensive treatment that combines cannabinoids and psilocybin for treating both physical and mental health concerns. Located in Issaquah, Washington, less than 20 miles southeast of Seattle, CaaMTech is aggressively researching the interactions between these two chemicals as well as the potential effects on physical and mental health. The initial stages of their enhanced… Read more.
Study Finds Car Insurance Premiums Dropped In Legal Medical Cannabis States By At Least $22 Per Driver According to a University of Iowa study, states that legalized medicinal marijuana saw a reduction in the cost of automobile insurance, which suggests that driving under the influence of cannabis may not be as risky as driving under the influence of alcohol. According to Cameron Ellis, professor of finance at the University of Iowa (U of I), states that legalized medicinal marijuana between 2014 and 2019 saw rates… Read more.
Combining cannabinoids with psilocybin into a single formula for treating both physical and mental health issues took another step closer to reality as described in a product patent from a major cannabinoid laboratory, CaaMTech. CaaMTech, based in Issaquah, Washington, less than 20 miles southeast of Seattle, is analyzing how the two substances interact with each other as well as the specific physical and mental health outcomes that can be expected. Their purified psilocybin-cannabinoid product is in the early development stages… Read more.
New Study Finds That Every Dollar Of Cannabis Sold Is Linked to a Reduction in Alcohol Sales …. A Threat To Big Alcohol? Big players in the alcohol industry have long been watching the development of legal cannabis with a careful eye, most especially with the launch of recreational cannabis markets in North America and beyond. While some players in the alcohol industry see cannabis legalization as a threat, others see it as a special opportunity to develop new products and attract a… Read more.
A top federal health agency is soliciting proposals for a series of research initiatives meant to explore how psychedelics could be used to treat drug addiction, with plans to provide $1.5 million in funding to support relevant studies. As public interest in the therapeutic potential of psychedelics continues to grow, the National Institute on Drug Abuse (NIDA) this week published three notices of funding opportunities (NOFOs) for research projects to better understand how drugs like psilocybin and ayahuasca could help… Read more.
Arizona Gov. Katie Hobbs (D) last week signed the state’s $17 billion budget bill into law; the budget includes about $5 million dedicated to whole-mushroom psilocybin research, the Arizona Mirror reports. Renowned medical cannabis and psychedelics researcher and principal investigator at the Scottsdale Research Institute Dr. Sue Sisley — who had pushed for the funding — said the $5 million was a good starting point for medical psilocybin trials. Additionally, the funding’s emphasis on whole mushroom research makes it unique from most other studies… Read more.
As there has been a rise in cases where seniors have consumed excessive amounts of cannabis, doctors caution seniors on the appropriate consumption methods. Consuming cannabis edibles, in particular, can lead to panic attacks if consumed without proper guidance, although the physical risks are typically minimal. According to a report from KOMO News in Seattle, doctors aim to educate seniors on preventing panic and avoiding unnecessary emergency room trips. This can be achieved through simple education about the distinct effects of edibles,… Read more.
New Frontier Data released a May 2 report titled "Cannabis Consumers in America 2023: Part 1." The study delves into the contemporary cannabis consumer's diverse demographics and trends. During a press release, Gary Allen, the CEO of New Frontier Data, claimed that more than 42% of adults who have consumed cannabis plan on using it again. Allen also explained that cannabis consumers fall under a broad range of genders, age groups, political affiliations, and economic backgrounds. The increase in cannabis use can… Read more.
When people talk about improving the quality of flower, the discussion is dominated by everything that happens before the harvest. Lighting, soil types, nutrients, pH, and a myriad of other inputs play a critical role in the development of a cannabis plant, but the quest for quality is far from over when the blade cuts through the stem on an outdoor farm in October. While it’s important to have healthy plants grown to their highest potential and potency, not putting enough planning and time into the… Read more.
Cannabis growers are looking closely at mainstream agricultural technology to gain a new level of precision cultivation that employs everything from artificial intelligence and augmented reality to robots and drones. The goals: better-quality cannabis, lower labor costs and improved productivity. Over the past few years, a host of AI-powered solutions have emerged to address: Cannabis growing methods, or protocols. Day-to-day labor savings. Growth-rate tracking. Yield forecasting. Inventory management. Profitability management. These are typically digital sensor-based systems managed by various platforms – Aroya,… Read more.
Even as more states have moved to legalize marijuana, rates of current and lifetime cannabis use among high school students have continued to drop, newly released federal data shows. The Centers for Disease Control and Prevention’s (CDC) Youth Risk Behavior Survey (YRBS), published last week, found that teen use of all monitored substances—including marijuana, alcohol and prescription drugs—has “decreased linearly” over the past decade. When it comes to cannabis, what’s especially notable is that the federal study shows high school… Read more.
The company asked its shareholders to reject a slate of directors offered up by FCM MM Holdings. Mind Medicine (MindMed) Inc. (Nasdaq: MNMD) (NEO: MMED) reported a net loss of $24.8 million for the first quarter ended March 31, compared with $18.5 million for the same period in 2022. The company does not have revenue to report at this time. Cash Levels As of March 31, MindMed had cash and cash equivalents totaling $129.4 million, compared with $142.1 million at the end of December 2022.… Read more.
Following the Senate’s rejection of a bill last week to require the Department of Veterans Affairs to conduct a study of veterans who use medical cannabis, Sen. John Tester (D-MT), chairman of the Senate Veterans Affairs Committee, told Military.com that the measure, and other veteran-focused bills, “may all be dead.” In a procedural vote last Wednesday, the Senate voted 57-42 to advance the cannabis bill, three votes short of the 60 required to pass. The bill, which included provisions related to the… Read more.
The study showed how mushroom extracts could boost immune cells in the brain. Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) stock jumped 11% to lately sell at four cents based on the release of a new study demonstrating how mushroom extract can help modulate brain health. The study, to be published in Frontiers in Pharmacology, shows that Amanita muscaria extract activates human microglia, which play a key role in maintaining brain function. These mushrooms are known to contain muscarine, muscimol, muscazone, and ibotenic acid and… Read more.
California marijuana regulators announced on Tuesday that they’ve awarded nearly $20 million in research grants to 16 academic institutions to carry out studies into cannabis, including novel cannabinoids like delta-8 THC and the genetics of “legacy” strains from the state. The research projects being funded by the California Department of Cannabis Control (DCC) with marijuana tax revenue fall under six categories: cannabis potency, medical usage, marijuana industry health, monopolies and unfair competition, California legacy genetics and miscellaneous studies. “It is… Read more.
The California Department of Cannabis Control (DCC) on Tuesday awarded $20 million in cannabis research grants to 16 academic institutions in the state. Rasha Salama, DCC chief deputy director, said the studies funded by the grants “will provide valuable insights on topics of interest to California’s consumers, businesses, and policy makers.” Eight of the studies are focused on cannabis potency, two on medical cannabis use, one on the health of the state’s cannabis industry, two on monopolies and unfair competition, one on… Read more.
Psilocybin, the primary psychoactive compound in "magic mushrooms," has been associated with recreational drug use and 1960s counterculture. However, recent research over the past two decades has shown that it can potentially treat various mental and behavioral health disorders. Health Canada has approved a comprehensive psilocybin trial on 160 patients, including macro and multi doses, by Apex Labs Ltd. This Canadian biopharmaceutical firm is also advancing at-home psilocybin microdose studies and supporting veteran patients. The trial has been deemed "statistically powered." SUMMIT-90… Read more.
A study published Thursday found that nematode worms under the influence of cannabis preferred high-calorie foods – behavior similar to humans when they get the munchies after consuming cannabis, according to a Washington Post report. Shawn Lockery, a University of Oregon Institute of Neuroscience professor, and one of the study’s authors, told the Post the study “helps us place ourselves in the universe of animals in a new way by reinforcing the commonality between humans, with this massive and marvelous brain, and a tiny… Read more.
Study of Dispensaries in 5 U.S. Cities Finds Dispensaries Strictly Enforce ID Verification Laws Given that the cannabis industry is relatively new, numerous individuals are well-acquainted with the rigorous compliance protocols associated with cannabis. To prevent underage customers from accessing products, cannabis vendors in the United States must adhere to various regulations established by state cannabis authorities, including verifying customer identification. According to a study published in the journal Addictive Behaviors, there is new insight into how dispensaries adhere to regulations.… Read more.
A Republican North Carolina lawmaker and a bipartisan group of cosponsors have filed a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort. The legislation from Rep. Edward Goodwin (R) wouldn’t legalize the psychedelics, but it would provide funding for two competitive grants through the state Department of Health and Human Services (HHS) for eligible research initiatives focused on… Read more.
University of Iowa (UI) researchers are conducting a pilot study using psilocybin and ketamine as a treatment for alcohol use disorder, the Daily Iowan reports. The study will be conducted as a head-to-head comparison of the compounds; half of the study participants will be given psilocybin and the other half will be given ketamine and neither the researchers nor the subjects will know which the participants will receive. Study participants will start by having an MRI scan and a meeting with a therapist.… Read more.
Results from an advanced clinical trial assessing psilocybin-assisted therapy for patients with cancer and Major Depressive Disorder (MDD) conducted by oncology center Sunstone Therapies were published in the acclaimed JAMA Oncology. The open-label Phase 2 study tested psilocybin paired with psychological support in 30 patients with curable and incurable cancer. Participants were divided into cohorts of 3 to 4 and each was given a 25 mg single dose of COMPASS CMPS-0.10%+ Free Alerts’ synthetic psilocybin COMP360. Dosing was done simultaneously on… Read more.
Clinical-stage biopharma company atai Life Sciences ATAI-6.00%+ Free Alerts announced the dosing of the first subject in majority-owned subsidiary Perception Neuroscience’s Phase 1 intravenous-to-subcutaneous bridging study of proprietary R-ketamine, PCN-101. Open-label, the trial is set to assess safety, tolerability and pharmacokinetic profile of 60mg, 90mg and 120mg of PCN-101 delivered subcutaneously as compared to 60mg of the compound delivered intravenously in 16 healthy volunteers across four cohorts. PCN-101 is a single isomer of ketamine and belongs to a new generation of glutamate receptor modulators -pharmacologically,… Read more.
A recent survey by Ayr Wellness found 40% of employed cannabis consumers plan to take off April 20 from work, with 31% of respondents saying 4/20 is a special occasion along with 42% of medical cannabis patients that agreed that 4/20 is an important day. In all, 23% of those polled indicated that their cannabis consumption habits would increase on 4/20 while 71% of respondents said their consumption habits would stay the same. David Goubert, president and CEO of AYR… Read more.
A study published last month by researchers at the University of North Texas Health Science Center and College of Applied Health Sciences, University of Illinois at Urbana-Champaign found one in 10 military veterans reported using cannabis over the past year. The study was published in the Substance Use & Misuse journal using data from the National Survey on Drug Use and Health (2013-2019) comprised of 16,350 veterans 18-years-or-older. The researchers found that veterans aged 65-and-older were more likely to define their cannabis use as… Read more.
A trial conducted by biotechnology company Small Pharma found that the psychedelic DMT could improve symptoms of depression when used in conjunction with therapy. In the study, which used intravenous DMT dosing, 14 participants out of 34 were in remission from depression within three months and nine remained in remission up to six months. The study, which utilized a proprietary synthetic formulation of DMT known as SPL026, has not been peer-reviewed. In a press release, Dr. Carol Routledge, chief medical and… Read more.
The Missouri House last week approved a measure that would require the state to conduct studies on psilocybin to treat depression, substance abuse, post-traumatic stress disorder, or use as part of end-of-life care, the Missouri Independent reports. This bill requires the state Department of Health and Senior Services (DHSS) to provide more than $2 million in grants for the research, subject to lawmakers approving the appropriation. The state would collaborate on the study with a Missouri university hospital or medical center operated by the U.S.… Read more.
When it comes to cannabis, most people assume the plant’s genetics are primarily responsible for an individual cultivar’s cannabinoid and terpene content. However, it turns out that cultivation practices may also play a significant role. A recent study published in the journal Molecules reveals how the growing process can impact the cannabis plant. A team from Colombia University, in conjunction with farmers in the famed Emerald Triangle, compared two genetically-identical strains—Red Velvet and Cheetah Piss—grown indoors and outdoors. The clones were from the same… Read more.
A chemical found in cannabis could be the most effective way to prevent an opioid overdose, scientists believe. Scientists at Indiana University have identified 15 chemicals derived from cannabidiol (CBD) — one of the primary compounds in cannabis — that can reverse the deadly impact drugs such as fentanyl can have on the brain. They found that it was even more effective than Narcan, designed to combat these type of overdoses, at stopping fentanyl in the brain. The finding could be a… Read more.
Federal marijuana trafficking cases continued to decline in 2022, according to the latest annual report from the U.S. Sentencing Commission (USSC). As more states have moved to legalize cannabis and federal priorities have shifted, prosecutions for marijuana-related cases have significantly declined over the years. The number of federal cannabis trafficking offenders has fallen from about 5,000 in 2013 to just under 806 last year, USSC found. Meanwhile, trafficking cases involving powder cocaine, fentanyl and methamphetamine increased from 2021 to 2022. The report also… Read more.
A recent study by the University of Sydney’s Lambert Initiative found 37% of respondents who use cannabis medically received a legal prescription under Australian law. In 2018, that figure was just 2.5%. The researchers found that those who only used prescription cannabis tended to be older, female, and less likely to be employed. Professor Nicholas Lintzeris, the lead researcher for the third Cannabis as Medicine Survey from the Faculty of Medicine and Health at the University of Sydney, said the data… Read more.
A congressional committee has approved a bill that aims to ramp up criminalization for fentanyl-related substances, while also streamlining research into Schedule I drugs like marijuana and certain psychedelics. The legislation, sponsored by Rep. Morgan Griffith (R-VA), passed the House Energy & Commerce Committee with amendments on Thursday. An amendment in the nature of a substitute was adopted by the panel, striking original provisions of the bill and replacing them with updated language that lays out penalties for fentanyl-related offenses… Read more.
New information and research about minor cannabinoids – among the 100-200 that have been identified – is helping treat different health and wellness conditions and allowing cannabis companies to sell a wider variety of products. The products go beyond the typical THC and CBD offerings currently on store shelves, and they incorporate lesser cannabinoids such as CBN and THCV. The new products – including edibles and vapes – allow cannabis companies to appeal to consumers seeking ways to address conditions… Read more.
A recent study claimed to show vaped CBD is more harmful than vaped nicotine, and while several news outlets have reported on it, they all missed numerous flaws in the methodology. As a result of numerous confounding variables, there is no way to actually show that any of the harms they found were from CBD, and not one of the many other chemicals in the oil. High Times spoke to several cannabis vaping experts in an effort to nip this story in the bud,… Read more.
Marijuana Legalization Linked to Reduction In Booze-Related Deaths of Pedestrians According to data, around 1 in every 7 pedestrian deaths is caused by a drunk driver. The National Highway Traffic Safety Administration states that some 32 people are killed due to drunk driving everyday. This equates to one death every 45 minutes, a senseless and completely unnecessary preventable death. The fact that alcohol consumption greatly impairs drivers has long been known, yet people continue to do it. Booze alters one’s judgment, severely impacts one’s ability to concentrate, affects… Read more.
Tennessee-based Gold Spectrum picked an inopportune day last month to debut an edibles line. On Feb. 13, the hemp company – which has five retail locations in Tennessee and sells products in other states – announced the release of several flavored “Delta 8 + THC-O Cereal Bars.” Popularized nationwide as a marijuana alternative since the passage of the 2018 Farm Bill, delta-8 THC can be found throughout states with no legal access, including Tennessee. But THC-O, also known as THC… Read more.
Texas lawmakers have filed a series of new bills aimed at promoting and expanding psychedelics research in the state. The Lone Star State took some observers by surprise last session after the conservative legislature enacted a measure to study the therapeutic potential of psychedelics—and now more legislators are hoping to build on that momentum. Three Democratic lawmakers in the state recently introduced separate reform proposals, including one that would expand the law that Gov. Greg Abbott (R) allowed to take effect… Read more.
Back in the 1950s, Humphry Osmond led a group of pioneering psychiatrists in an extensive study of psychedelics. And from that research, they found that these hallucinogenic drugs had immense therapeutic potential. With academic research coming to an indisputable conclusion and mental health awareness on the rise, the legal landscape is starting to peel back antiquated laws that were put in place 50 years ago. In creating a superior treatment for mental health disorders, the Shroom Boom will give rise… Read more.
In the early 1960s, a Bulgarian-born scientist named Raphael Mechoulam was caught carrying five kilograms of, as he called it, “superb, smuggled Lebanese hashish” on a bus from Tel Aviv to Rehovot. But he wasn’t planning on smoking the stuff. Mechoulam was a fledgling researcher keen on exploring the science behind cannabis, a stigmatized plant whose specific medical properties were not yet known. Over the decades he became a pioneer in cannabis research, whose findings about the psychoactive substance helped ease… Read more.
Military veterans trying to overcome the horrors of war are increasingly finding themselves in an unlikely position — persuading Republican politicians to legalize the healing power of ancient psychedelic plants. DailyMail.com spoke with former Marines, Navy Seals and others left traumatized by America's brutal campaigns overseas who have turned to psilocybin mushrooms and other natural drugs to help fight their inner demons. Left-leaning Oregon and Colorado have started to let psilocybin, the psychoactive ingredient in 'magic' mushrooms, be used in supervised drug journeys to counter depression and… Read more.
The room resembles an unassuming Ikea showroom, with cream-colored walls, a white fur rug and a simple twin-sized bed. Potted plants frame each side of the room with an orange lamp and a bag of blue corn chips atop asymmetric tables. The only indicator that something is abnormal is the two chairs at the front of the room facing the bed. Indeed, this is no ordinary bedroom. It is the site where patients are given psilocybin — commonly known as… Read more.
As former general manager of three Arena Football League teams, Reggie Harris knows the importance of going on offense. So, in 2021, when Harris and his team launched House of Kush, a Kansas City, Missouri-based company that sells cannabis-plant genetics via seedlings and licensing deals, he didn’t wait for clients to come find him. “Primarily, we’re going out seeking them,” Harris said. Today, House of Kush genetics are growing in six states – Arizona, California, Maryland, Michigan, Missouri and Oklahoma… Read more.
Do psychedelics like mushrooms and LSD have anti-aging effects? Dr. Andrew Steele, a physics professor who has ventured into the field of biology, presents a fascinating perspective on longevity in his new book. He emphasizes that it's not cancer or heart disease but aging that is the root cause of the most significant suffering and deaths worldwide. Dr. Steele proposes that by finding pharmacological remedies that target the cells responsible for degrading tissue function, we could unlock the potential for… Read more.
Changes will likely start to happen sometime soon, and margins could rise as a result. With an ever-growing abundance of easy-to-use artificial intelligence (AI) tools for business exploding onto the scene in late 2022, the AI revolution is in full swing, and it won't leave many sections of the economy untouched. But the cannabis industry isn't an obvious candidate for disruption by AI software tools. Most of the cultivation, manufacturing, and retail processes are based on lots of manual labor… Read more.
BURTON, Mich. — Before Jayden Carter turned 9, police were called 126 times to his school, home and other locations to address his violent behavior. “I had ribs out of place, my forehead cut open, black eye,” recalled Amie Carter, his mother. The situation got so dire that Child Protective Services encouraged Amie to sign her rights to Jayden away, a step that would allow the state to put him in permanent treatment. That was when — out of… Read more.
Using marijuana every day can raise a person’s risk of coronary artery disease, or CAD, by a third compared with those who never partake, a new study found. “A growing body of evidence suggests that cannabis is not entirely without harm and may actually cause cardiovascular disease,” said lead study author Dr. Ishan Paranjpe, a resident physician at Stanford University. The study — which has not yet been published -— will be presented Sunday at the annual meeting of the… Read more.
As many U.S. states adopt policies that legalize the commercialization of cannabis, Yale School of Medicine recently announced the creation of the new Yale Center for the Science of Cannabis and Cannabinoids, which will investigate the acute and chronic effects of cannabis and cannabinoids on neurodevelopment and mental health. Its inaugural director will be Deepak Cyril D’Souza, the Albert E. Kent Professor of Psychiatry and an expert in the pharmacology of cannabinoids. The new center comes just as retail cannabis sales begins in… Read more.
John Oliver is back on “Last Week Tonight” and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic assisted therapy. The show, which aired on Sunday, delves into the history of psychedelics and its potential benefits for mental health. After classically making fun of himself, Oliver, a self-proclaimed drug connoisseur, goes on to look into the different uses of psychedelics, including spirituality, healing, and recreation, throughout the centuries. However, the show focuses on the use… Read more.
A study published last month in the Journal of Cannabis Research suggests that cannabis use has a positive impact on sexual quality. In the study, an online survey of 811 people, more than 70% of respondents reported increased sexual desire and orgasm intensity with cannabis use and more than 40% of the women surveyed indicated an “increased ability to have more than one orgasm per sexual encounter.” The majority of study participants identified as female (64.9%), white (78.9%), and college-educated (80.1%). Twenty-three… Read more.
Florian Brand knows that there aren’t many people with his profile in biopharma. “You would probably consider me an outlier,” says the 36-year-old chief executive of Germany’s up-and-coming Atai Life Sciences. He doesn’t have a Ph.D. or any scientific background. His previous gig was running an online cookware retailer. But he does possess a history of profound experiences with mental health—experiences that left such an impression that four years ago he dropped everything to cofound Atai, a biopharmaceutical company now backed… Read more.
The DEA Wants to Double the Amount of Cannabis & Psychedelics Grown for Research This Doesn’t Seem Like Good News The Drug Enforcement Administration (DEA) released a notice earlier this month, announcing their intention of proposing a much larger increase in cannabis to be grown for research by next year. The notice specifically mentions they want to boost the production of psychedelics including psilocin, mescaline, and LSD, reports Marijuana Moment. The notice proposed the production of some 14,770 pounds of marijuana for 2023.… Read more.
Brand New Study Shows How Psychedelics Light Up Neuropathways In The Brain - More Fascinating Insight Into How Psychedelics Work Psychedelics are all the rage right now. And for good reason: these trippy substances have so much more therapeutic value than we thought. Drugs that were once used for recreation have been proven to have physical and mental benefits, treating several ailments that even pharmaceutical drugs have failed to despite being around for several decades. Plus, psychedelics don’t have the same side effects… Read more.
NYC and Cambridge-based Empyrean Neuroscience Inc. is a new genetic engineering company developing neuroactive compounds for neuropsychiatric and neurological disorders launching with a $22 million Series A financing. The company’s CEO is long-time biotech executive Dr. Usman “Oz” Azam, joined by Dr. Fred Grossman as chief medical officer. Azam has previously worked on genetic engineering with Dr. Carl June of the University of Pennsylvania, while Grossman is a psychiatrist that holds expertise in CNS-targeted small molecules development. Both leadmen say the goal is to target the demand gap within… Read more.
Pennsylvania officials announced on Monday that they will be providing up to $200,000 in matched funding for marketing projects to promote the state’s hemp market. The state Department of Agriculture said that non-profit organizations that take on marketing initiatives to increase hemp sales, exports or consumer awareness of the sector of the cannabis industry are eligible for the reimbursement funds. “Hemp has presented a unique opportunity to grow an industry from the ground up, supplying seemingly limitless sustainable construction materials,… Read more.
The prominence of medicinal cannabis and its acceptance in recent times has been majorly built on the effects of cannabinoids. Along with terpenes and other phytochemical molecules, they give rise to a wide range of medicinal effects and recreational effects. However, a recent discovery by Professor Raphael Mechoulam who is known as the father of cannabis research might soon change the world of what we know about cannabis and cannabinoids. What is this discovery? How important is it to the previously established… Read more.
X-ray technology company VJ Group announced on Wednesday that it has launched VJ Scientific, a new cannabis division that will provide product decontamination equipment to the regulated marijuana industry. The company also revealed the new enterprise’s initial product offering, which it characterized as “a revolutionary non-thermal, non-chemical cannabis decontamination machine.” Dubbed the CX-1000, the new cannabis decontamination solution will be debuted next month at MJBizCon in Las Vegas. Commercial cannabis cultivation carries the risk of contamination from an array of… Read more.
New research shows that people who use weed are no more likely to be unmotivated compared to people who don’t. The lazy stoner stereotype has long been the go-to depiction of people who use cannabis in mainstream media and a pillar of anti-drug campaigns worldwide. But a new study suggests that the representation of people who use weed as lazy and unmotivated might be lazy in itself. The study, led by scientists at the University of Cambridge, University College London, and King’s College London, and published in the… Read more.
Researcher Beatriz Carlini clicks through a few local cannabis retailers’ websites before finding what she’s looking for. Her screen displays a yellow goo, similar in appearance to raw honey, or as the product’s marketing calls it, “Cake Batter.” The substance is a highly concentrated form of cannabis called a dab, which is produced by extracting the psychoactive compound THC from cannabis plants. It’s usually vaporized and inhaled using a device that looks similar to a bong, but often involves a… Read more.